NRx Pharmaceuticals, Inc

NRXPNASDAQ · Pharmaceutical Preparations

Financing

SEC filings to 2026-10-05 · every row opens its filing

Shares on issue

43.2M

on 2026-06-30, from 9.77M on 2024-03-31 10-Q ↗

a raise that quarter, at its price

Newest

Filed

S-3 of 2025-06-20. Size not read. 1 prospectus supplement filed under it since. S-3 ↗

$20.0M

Agreement of 2026-02-17. No at-the-market sales statement read from a 10-Q or 10-K. 424B5 ↗

Warrants

8.99M

Warrants of every class as tagged in the XBRL facts on 2026-06-30. 10-Q ↗

Cash

5.4 quarters

$26.7M on 2026-06-30 ÷ $4.9M a quarter of operating cash used, the average of four quarters. 10-Q ↗

Raised
Date	What	Shares	Price	Gross	Filing
2026-06-03	Public offering	5,714,286	$3.50	$20.0M	424B5 ↗
2025-08-18	Public offering	3,959,999	$1.65	$6.5M	424B5 ↗
2025-01-29	Registered direct offering	1,215,278	$2.88	$3.5M	8-K ↗
2025-01-28	Private placement	732,600	$2.73	not stated	8-K ↗
2025-01-27	Public offering	1,215,278	not read	not read	424B3 ↗
2025-01-05	Private placement	not read	$2.74	$2.0M	8-K ↗